中文产业新闻评分52Chinese source
Ultragenyx以2.1亿美元出售罕见儿科疾病PRV
2.1亿美元，又见天价PRV(罕见儿科疾病优先审评券)
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
2.1亿美元，又见天价PRV(罕见儿科疾病优先审评券)
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.